October 22, 2024 RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury Read More October 14, 2024 RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment ...
RedHill is at the forefront of pandemic preparedness and medical countermeasures efforts, developing two novel, potentially broad-acting, host-directed, late-stage, oral, small molecule therapies, with intrinsic viral mutation-resistant properties, suitable for stockpiling and easy distribution and administ...
手机东方财富网是东方财富网的手机门户网站,为亿万用户打造一个手机联通世界的超级平台,提供7*24小时全面及时的财经中文资讯,内容覆盖国内外突发事件、股市资讯、全球新闻、产业资讯、实用信息等。手机东方财富网触屏版 - eastmoney.com
Redhill Biopharma的新闻 RedHill:预计新冠肺炎候选药物Opaganib不受刺突蛋白突变影响 特种生物制药公司Redhill Biopharma Ltd。今日宣布,由于Opaganib的拟议作用机制不受刺突蛋白突变的影响,预计Opaganib不会受到与奥密克戎及其他已知须关切变体相关突变的影响。 网页链接Redhill...
最近访问:RedHill Biopharma Ltd ADR --- 全球指数美股行情美股吧国际期货 - -- 今开: - 最高价: - 成交量: - 外盘: - 昨收: - 最低价: - 成交额: - 内盘: - 总股本: - 振幅: - 换手率: - 每股收益TTM: - 总市值: - 市净率MRQ: - ...
最近访问:RedHill Biopharma Ltd ADR --- 全球指数美股行情美股吧国际期货 - -- 今开: - 最高价: - 成交量: - 外盘: - 昨收: - 最低价: - 成交额: - 内盘: - 总股本: - 振幅: - 换手率: - 每股收益TTM: - 总市值: - 市净率MRQ: - ...
$Redhill Biopharma(RDHL)$6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002975 Act: 34 Size: 14 KB网页链接 财报披露 Redhill Biopharma(RDHL)10-15 18:15 $Redhill Biopharma(RDHL)$6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession...
In September 2021 RedHill Biopharma Inc., AstraZeneca AB, AstraZeneca Pharmaceuticals LP and Nektar Therapeutics entered into a settlement and license agreement with Aurobindo Pharma USA, Inc. resolving their patent litigation in the U.S. in response to Aurobindo's Abbreviate...
Redhill Biopharma Ltd是一家专注于胃肠道疾病的专业生物制药公司。该公司主要专注于推进其临床阶段治疗候选药物的开发管道。 该公司还在美国销售胃肠道相关产品 Talicia(奥美拉唑、阿莫西林和利福布丁)和 Aemcolo(利福霉素。 该公司目前的产品线由五种治疗候选药物组成,分别是Opaganib、RHB-107、RHB-102、RHB-204和RHB-...
Redhill Biopharma Ltd是一家专注于胃肠道疾病的专业生物制药公司。该公司主要专注于推进其临床阶段治疗候选药物的开发管道。 该公司还在美国销售胃肠道相关产品 Talicia(奥美拉唑、阿莫西林和利福布丁)和 Aemcolo(利福霉素。 该公司目前的产品线由五种治疗候选药物组成,分别是Opaganib、RHB-107、RHB-102、RHB-204和RHB-...